Who owns IMAGENEBIO INC?
- Ticker: IMA
- CUSIP Number: 45175g207
Tip: Access positions for across all investors
Analyze quarterly positions in Imagenebio with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Imagenebio stock
Who bought or sold IMAGENEBIO INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 1.1M | $5.6M | 38% | Mar 2026 |
|
| Blue Owl Capital Holdings | 824k | $5.7M | 52% | Dec 2025 |
|
| Cable Car Capital | 755k | $3.8M | 17% | Mar 2026 |
|
| Omega Fund Management | 455k | $3.1M | 0% | Dec 2025 |
|
| OrbiMed Advisors | 379k | $1.9M | 0% | Mar 2026 |
|
| Rtw Investments | 334k | $2.3M | 0% | Dec 2025 |
|
| Vanguard Capital Management | 325k | $1.6M | 100% | Mar 2026 |
|
| Vanguard Group | 238k | $1.6M | 2% | Dec 2025 |
|
| BML Capital Management | 201k | $1.0M | 13% | Mar 2026 |
|
| BlackRock | 129k | $646k | -2% | Mar 2026 |
|
| Citadel Advisors | 124k | $622k | 44% | Mar 2026 |
|
| Adage Capital Partners GP | 67k | $460k | 0% | Dec 2025 |
|
| Renaissance Technologies | 66k | $456k | 77% | Dec 2025 |
|
| Geode Capital Management | 60k | $300k | 11% | Mar 2026 |
|
| NEA Management Company | 50k | $250k | 0% | Mar 2026 |
|
| Hsbc Holdings | 35k | $166k | 2% | Mar 2026 |
|
| Rangeley Capital | 33k | $163k | 79% | Mar 2026 |
|
| Sofinnova Ventures | 32k | $159k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 27k | $136k | 100% | Mar 2026 |
|
| Jacobs Levy Equity Management | 27k | $133k | 42% | Mar 2026 |
|
| Nano Cap New Millennium Growth Fund | 27k | $183k | 100% | Dec 2025 |
|
| Shay Capital | 19k | $96k | 100% | Mar 2026 |
|
| Aldebaran Capital | 19k | $93k | -3% | Mar 2026 |
|
| Morgan Stanley | 18k | $92k | 70% | Mar 2026 |
|
| Hrt Financial | 14k | $69k | 100% | Mar 2026 |
|
| Springbok Capital Management | 14k | $93k | 100% | Dec 2025 |
|
| Jane Street | 13k | $66k | -11% | Mar 2026 |
|
| XTX Topco | 12k | $84k | -73% | Dec 2025 |
|
| Goldman Sachs Group | 12k | $57k | 5% | Mar 2026 |
|
| Barclays | 11k | $75k | 171% | Dec 2025 |
|
| UBS Group | 5.4k | $27k | 9% | Mar 2026 |
|
| Royal Bank of Canada | 1.0k | $5.0k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 602.00 | $3.0k | 100% | Mar 2026 |
|
| Citigroup | 224.00 | $1.1k | 100% | Mar 2026 |
|
| Goss Wealth Management | 160.00 | $800.000000 | -67% | Mar 2026 |
|
| Wells Fargo & Company | 41.00 | $205.000000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 24.00 | $120.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $10.000000 | 100% | Mar 2026 |
|
Who sold out of Imagenebio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Atlas Venture Life Science Advisors | Sep 2025 | 378k | $3.1M |
| Monashee Investment Management | Dec 2025 | 92k | $632k |
| Squarepoint Ops | Dec 2025 | 48k | $333k |
| DRW Holdings | Dec 2025 | 44k | $302k |
| None | Dec 2025 | 23k | $160k |
| Bridgeway Capital Management | Sep 2025 | 13k | $104k |
| Millennium Management | Dec 2025 | 12k | $79k |
| Tower Research Capital | Sep 2025 | 877.00 | $7.1k |
| Fortitude Family Office | Dec 2025 | 400.00 | $2.8k |
| Jpmorgan Chase & Co | Sep 2025 | 70.00 | $570.997000 |
| FMR | Sep 2025 | 67.00 | $546.003100 |
| Efficient Wealth Management | Dec 2025 | 57.00 | $0 |